We provide you with 20 years of free, institutional-grade data for BBIO stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of BBIO. Explore the full financial landscape of BBIO stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$33,563,801
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| MCCORMICK FRANK | Sale | -74,000 | $53.16 | $3,933,544 | 2025-09-08 |
| MCCORMICK FRANK | Derivatives Exercise | 74,000 | 2025-09-08 | ||
| Kumar Neil | Sale | -40,000 | $51.16 | $2,046,268 | 2025-09-08 |
| Kumar Neil | Sale | -40,000 | $51.15 | $2,046,016 | 2025-09-08 |
| Kumar Neil | Sale | -26,156 | $48.81 | $1,276,740 | 2025-08-22 |
| Trimarchi Thomas | Sale | -42,237 | $49.48 | $2,090,081 | 2025-08-22 |
| Trimarchi Thomas | Sale | -38,670 | $51.32 | $1,984,544 | 2025-08-19 |
| Kumar Neil | Sale | -32,855 | $51.32 | $1,686,119 | 2025-08-19 |
| Kumar Neil | Derivatives Exercise | 64,697 | 2025-08-19 | ||
| Apuli Maricel | Sale | -4,781 | $51.32 | $245,361 | 2025-08-19 |
| BridgeBio Pharma LLC | Initial | 2025-08-18 | |||
| HOMCY CHARLES J | Sale | -300,000 | $45.87 | $13,761,090 | 2025-08-12 |
| Kumar Neil | Sale | -40,000 | $45.09 | $1,803,708 | 2025-08-11 |
| Kumar Neil | Sale | -40,000 | $45.09 | $1,803,708 | 2025-08-11 |
| Apuli Maricel | Sale | -1,000 | $45.44 | $45,440 | 2025-08-11 |
| Ellis Andrea | Sale | -17,167 | $49 | $841,183 | 2025-08-07 |
| Ellis Andrea | Derivatives Exercise | 17,167 | 2025-08-07 | ||
| Kumar Neil | Sale | -40,000 | $42.51 | $1,700,200 | 2025-07-03 |
| Kumar Neil | Sale | -40,000 | $42.5 | $1,700,060 | 2025-07-03 |
| VIKING GLOBAL INVESTORS LP | Sale | -3,500,000 | $44 | $154,000,000 | 2025-07-01 |
| Valantine Hannah | Sale | -2,289 | $44.13 | $101,005 | 2025-06-30 |
| Valantine Hannah | Sale | -2,418 | $44.11 | $106,658 | 2025-06-30 |
| Valantine Hannah | Open Market Purchase | 796 | $13.16 | 2025-06-30 | |
| Valantine Hannah | Open Market Purchase | 3,294 | $12.68 | 2025-06-30 | |
| MCCORMICK FRANK | Sale | -100,000 | $44.23 | $4,422,800 | 2025-06-26 |
| AGUIAR ERIC | Grant, award...etc | 6,589 | 2025-06-24 | ||
| DANIELS RONALD J | Grant, award...etc | 6,589 | 2025-06-24 | ||
| Satvat Ali J. | Grant, award...etc | 6,589 | 2025-06-24 | ||
| MOMTAZEE JAMES C | Grant, award...etc | 6,589 | 2025-06-24 | ||
| HOMCY CHARLES J | Grant, award...etc | 6,589 | 2025-06-24 | ||
| Hassan Fred | Grant, award...etc | 6,589 | 2025-06-24 | ||
| Dachille Douglas A. | Grant, award...etc | 6,589 | 2025-06-24 | ||
| Scott Randal W. | Grant, award...etc | 6,589 | 2025-06-24 | ||
| Valantine Hannah | Grant, award...etc | 6,589 | 2025-06-24 | ||
| Cook Jennifer E. | Grant, award...etc | 6,589 | 2025-06-24 | ||
| MCCORMICK FRANK | Grant, award...etc | 6,589 | 2025-06-24 | ||
| Ellis Andrea | Grant, award...etc | 6,589 | 2025-06-24 | ||
| Lo Andrew | Grant, award...etc | 6,589 | 2025-06-24 | ||
| Valantine Hannah | Sale | -4,292 | $40 | $171,680 | 2025-06-11 |
| Valantine Hannah | Derivatives Exercise | 4,292 | 2025-06-11 | ||
| Trimarchi Thomas | Sale | -21,317 | $33.84 | $721,367 | 2025-05-20 |
| Apuli Maricel | Sale | -4,780 | $33.84 | $161,755 | 2025-05-20 |
| Kumar Neil | Sale | -75,000 | $33.4 | $2,504,978 | 2025-05-20 |
| Kumar Neil | Sale | -59,010 | $33.84 | $1,996,898 | 2025-05-20 |
| Kumar Neil | Derivatives Exercise | 64,696 | 2025-05-20 | ||
| KKR Genetic Disorder L.P. | Sale | -6,000,000 | $34.2 | $205,200,000 | 2025-05-14 |
| Lo Andrew | Sale | -100,000 | $38.5 | $3,849,900 | 2025-05-06 |
| Apuli Maricel | Sale | -1,026 | $38.51 | $39,509 | 2025-05-06 |
| Kumar Neil | Sale | -75,000 | $34.11 | $2,558,025 | 2025-04-24 |
| Ellis Andrea | Sale | -10,000 | $35 | $350,000 | 2025-04-16 |
| Ellis Andrea | Derivatives Exercise | 10,000 | 2025-04-16 | ||
| Ellis Andrea | Sale | -30,000 | $34.05 | $1,021,500 | 2025-04-03 |
| Ellis Andrea | Derivatives Exercise | 30,000 | 2025-04-03 | ||
| Kumar Neil | Sale | -75,000 | $36.87 | $2,764,943 | 2025-03-27 |
| Apuli Maricel | Grant, award...etc | 23,660 | 2025-03-21 | ||
| Trimarchi Thomas | Grant, award...etc | 109,100 | 2025-03-21 | ||
| Valantine Hannah | Sale | -12,875 | $32.58 | $419,500 | 2025-03-10 |
| Valantine Hannah | Derivatives Exercise | 12,875 | 2025-03-10 | ||
| KKR Genetic Disorder L.P. | Sale | -6,000,000 | $32.96 | $197,760,000 | 2025-03-07 |
| Apuli Maricel | Initial | 2025-02-27 | |||
| STEPHENSON BRIAN C | Sale | -8,500 | $33.18 | $282,015 | 2025-02-27 |
| STEPHENSON BRIAN C | Derivatives Exercise | 8,500 | 2025-02-27 | ||
| Kumar Neil | Sale | -75,000 | $33.36 | $2,502,270 | 2025-02-27 |
| Kumar Neil | Sale | -55,539 | $34.9 | $1,938,311 | 2025-02-19 |
| Kumar Neil | Derivatives Exercise | 55,539 | 2025-02-19 | ||
| Trimarchi Thomas | Sale | -13,782 | $34.9 | $480,992 | 2025-02-19 |
| STEPHENSON BRIAN C | Sale | -17,250 | $34.9 | $602,025 | 2025-02-19 |
| STEPHENSON BRIAN C | Derivatives Exercise | 25,798 | 2025-02-19 | ||
| VIKING GLOBAL INVESTORS LP | Sale | -3,065,616 | $34.9 | $106,989,998 | 2025-01-31 |
| Kumar Neil | Sale | -600,000 | $36.29 | $21,772,200 | 2025-01-30 |
| STEPHENSON BRIAN C | Sale | -68,000 | $36.29 | $2,467,761 | 2025-01-30 |
| STEPHENSON BRIAN C | Derivatives Exercise | 68,000 | 2025-01-30 | ||
| Satvat Ali J. | Derivatives Exercise | 159,404 | 2024-12-31 | ||
| Trimarchi Thomas | Grant, award...etc | 50,000 | 2024-12-12 | ||
| STEPHENSON BRIAN C | Sale | -4,156 | $22.41 | $93,137 | 2024-11-20 |
| Kumar Neil | Sale | -27,389 | $22.39 | $613,119 | 2024-11-20 |
| STEPHENSON BRIAN C | Sale | -13,077 | $23.72 | $310,186 | 2024-11-19 |
| STEPHENSON BRIAN C | Derivatives Exercise | 25,799 | 2024-11-19 | ||
| Kumar Neil | Sale | -28,148 | $23.72 | $667,671 | 2024-11-19 |
| Kumar Neil | Derivatives Exercise | 55,537 | 2024-11-19 | ||
| Trimarchi Thomas | Sale | -17,936 | $23.72 | $425,442 | 2024-11-19 |
| KKR Genetic Disorder L.P. | Sale | -5,800,000 | $25.75 | $149,350,000 | 2024-09-17 |
| Trimarchi Thomas | Sale | -17,936 | $24.4 | $437,638 | 2024-08-20 |
| STEPHENSON BRIAN C | Sale | -17,232 | $24.4 | $420,461 | 2024-08-20 |
| STEPHENSON BRIAN C | Derivatives Exercise | 25,797 | 2024-08-20 | ||
| Kumar Neil | Sale | -55,537 | $24.4 | $1,355,103 | 2024-08-20 |
| Kumar Neil | Derivatives Exercise | 55,537 | 2024-08-20 | ||
| Trimarchi Thomas | Grant, award...etc | 19,003 | 2024-08-08 | ||
| Trimarchi Thomas | Initial | 2024-07-29 | |||
| Scott Randal W. | Sale | -2,500 | $28.68 | $71,711 | 2024-06-05 |
| STEPHENSON BRIAN C | Sale | -13,943 | $31.04 | $432,791 | 2024-05-17 |
| STEPHENSON BRIAN C | Derivatives Exercise | 27,507 | 2024-05-17 | ||
| Kumar Neil | Sale | -30,748 | $31.04 | $954,418 | 2024-05-17 |
| Kumar Neil | Derivatives Exercise | 60,667 | 2024-05-17 | ||
| Scott Randal W. | Sale | -2,500 | $34 | $85,000 | 2024-03-05 |
| Kumar Neil | Sale | -47,922 | $37.21 | $1,783,178 | 2024-02-21 |
| Kumar Neil | Derivatives Exercise | 102,249 | 2024-02-21 | ||
| STEPHENSON BRIAN C | Sale | -18,919 | $37.21 | $703,976 | 2024-02-21 |
| STEPHENSON BRIAN C | Derivatives Exercise | 44,996 | 2024-02-21 | ||
| HOMCY CHARLES J | Sale | -1,509 | $37.21 | $56,150 | 2024-02-21 |
| HOMCY CHARLES J | Derivatives Exercise | 3,760 | 2024-02-21 | ||
| Valantine Hannah | Sale | -2,915 | $37.75 | $110,041 | 2024-02-20 |
| Valantine Hannah | Derivatives Exercise | 2,915 | 2024-02-20 | ||
| Valantine Hannah | Open Market Purchase | 3,433 | $13.18 | 2024-02-13 | |
| Valantine Hannah | Sale | -2,915 | $37.97 | $110,683 | 2024-01-18 |
| Valantine Hannah | Derivatives Exercise | 2,915 | 2024-01-18 | ||
| MCCORMICK FRANK | Sale | -100,000 | $42.06 | $4,206,000 | 2023-12-28 |
The information provided in this report about BBIO stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
BridgeBio Pharma, Inc(NASDAQ:BBIO) 
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs inc...
Website: http://www.bridgebio.com
Founded: 2015
IPO Price: $17 (Jun 27, 2019)
Full Time Employees: 369
CEO: Neil Kumar
Sector: Healthcare
Industry: Biotechnology